Evidence map›Paper›PMID 39205423›Full record

ArticleTurkish journal of ophthalmology2024

Treatment of Behçet Uveitis in Türkiye.

Pınar Çakar Özdal, Fatime Nilüfer Yalçındağ, Yasemin Özdamar Erol, Merih Soylu, İlknur Tuğal-Tutkun

Abstract read
In one paragraph

Article in Turkish journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pınar Çakar ÖzdalUniversity of Health Sciences Türkiye, Ulucanlar Eye Training and Research Hospital, Clinic of Ophthalmology, Ankara, Türkiye.ORCID 0000-0002-5714-7172
Fatime Nilüfer YalçındağAnkara University Faculty of Medicine, Department of Ophthalmology, Ankara, Türkiye.ORCID 0000-0002-8963-5146
Yasemin Özdamar ErolUniversity of Health Sciences Türkiye, Etlik City Hospital, Clinic of Ophthalmology, Ankara, Türkiye.ORCID 0000-0002-0406-8921
Merih SoyluPrivate Eye Clinic, Adana, Türkiye.ORCID 0000-0002-4037-7641
İlknur Tuğal-Tutkunİstanbul Bayrampaşa Eye Hospital, İstanbul, Türkiye.ORCID 0000-0002-4020-453X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Behçet uveitis (BU) is a potentially blinding disorder. The main determinant of visual prognosis is early and appropriate treatment that provides rapid suppression of inflammatory attacks, control of subclinical inflammation, and prevention of new attacks. Our study aimed to determine the Turkish uveitis specialists' approach regarding the treatment choices and management of special situations such as pregnancy, vaccination, and surgical planning in BU patients, and to increase information sharing and raise awareness of issues where knowledge is lacking. Materials and Methods: A web-based survey including 16 questions about the treatment approach in ocular involvement of Behçet's disease was sent via e-mail to uveitis specialists in Türkiye. Based on the answers of 49 ophthalmologists who responded to the survey, we evaluated the approaches of uveitis specialists in our country to initiating treatment, selecting therapeutic agents, monitoring, switching and stopping treatment, and special situations such as surgical planning, vaccination, and pregnancy in BU patients. Results: Uveitis specialists in our country mostly act in accordance with the guidelines in the decision to start treatment, selection of therapeutic agents, and monitoring the safety of treatment in BU. However, there is a lack of information about the therapeutic approach in pregnancy and vaccination practices. It was also observed that there is no consensus on the precautions to be taken before cataract surgery. Conclusion: Our study has shown that there is a need for more detailed and widespread information sharing on treatment in preparation for ocular surgery, safety monitoring, drug use during pregnancy, and vaccination in BU patients.

Indexed as

Behcet SyndromeAdultFemaleHumansImmunosuppressive AgentsMalePregnancySurveys and QuestionnairesTurkeyUveitisImmunosuppressive AgentsBehçet syndromepregnancytherapeuticsuveitisvaccination

Identifiers

PMID39205423
PMCPMC11590712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.